Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Losartan (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics; Therapeutic Use
- 20 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated
- 20 Nov 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.